Viking Therapeutics (VKTX) EPS (Basic) (2014 - 2026)
Viking Therapeutics (VKTX) posted EPS (Basic) of -$2.27 for Q2 2026, up 1.52% sequentially from -$2.3 in Q1 2026, and down 68.62% YoY from -$7.23 in Q2 2025.
Powered by 
Analysis
Viking Therapeutics (VKTX) EPS (Basic) (2014 - 2026) Analysis & Trends
Viking Therapeutics has reported EPS (Basic) for 13 years, with the latest figure at -$2.27 in Q2 2026.
- Quarterly EPS (Basic) fell 68.62% year-over-year to -$2.27 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$8.44 (down 22.69% YoY) and the FY2025 annual result came in at -$4.49, down 55.53% from the prior year.
- EPS (Basic) grew to -$2.27 in Q2 2026 per VKTX's latest filing, from -$2.3 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.23 in Q3 2022 and troughed at -$768.41 in Q1 2023.
- A 5-year average of -$84.8 and a median of -$2.11 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) tumbled 314896.78% in 2023, then surged 99.53% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.52 in 2022, then plunged by 84.18% to -$0.96 in 2023, then tumbled by 102.07% to -$1.95 in 2024, then fell by 26.97% to -$2.47 in 2025, then gained by 8.18% to -$2.27 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$2.27, -$2.3, and -$2.47 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Viking Therapeutics | 4.00 Bn | 4.00 Bn | - | -1.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10 |
| Mar 31, 2026 | -1.37 |
| Dec 31, 2025 | -1.40 |
| Sep 30, 2025 | -0.81 |
| Jun 30, 2025 | -0.58 |
| Mar 31, 2025 | -0.41 |
| Dec 31, 2024 | -0.32 |
| Sep 30, 2024 | -0.23 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.26 |
| Dec 31, 2023 | -0.26 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.19 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -0.25 |
| Sep 30, 2022 | -0.21 |
| Jun 30, 2022 | -0.23 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.17 |